How to Tell If Your Low Blood Pressure Is Dangerously Low? All On Living With Hypotension
Low blood pressure, also known as hypotension, is usually considered a sign of good health and low risk for cardiovascular disease. However, there are times when persistently low blood pressure or a sudden drop can be a sign of an underlying health issue that needs medical attention. Knowing when low blood pressure becomes a problem can help ensure timely intervention and proper care.
Systolic pressure (the top number) indicates the pressure in your arteries when your heart pumps blood. Diastolic pressure (the bottom number) reflects the pressure in your arteries while your heart is resting between beats.
The normal reading is usually 120/80 mmHg or less. Hypotension is clinically defined as having blood pressure readings less than 90/60 mmHg. In some patients, low blood pressure will have no adverse health consequences and therefore does not need to be treated. In extreme cases, however, it can limit the flow of oxygen and nutrients to vital organs, resulting in potentially life-threatening complications, such as shock.
Hypotension can result from many factors. Some of the factors that cause hypotension are as follows:
While low blood pressure may not always cause symptoms, it can sometimes be associated with:
- Dizziness or fainting
- Fatigue and weakness
- Blurred vision
- Nausea
- Confusion or difficulty concentrating
- Shallow breathing
- Palpitations
If the person experiences these symptoms, with the recorded blood pressure reading, the medical services have to be consulted.
1. Orthostatic Hypotension: This is a kind of hypotension that appears as a result of decreased blood pressure when a person is standing up from lying down or sitting position and primarily affects elderly people.
2. Postprandial Hypotension: This is a drop in blood pressure after eating, more common in older people.
3. Neurally Mediated Hypotension: It is triggered by standing for long periods. This type can affect younger people and is associated with miscommunication between the brain and heart.
There is no such thing as a universal threshold for very low blood pressure, but a blood pressure reading below 90/60 mmHg can be dangerous and require prompt medical assessment if accompanied by symptoms of fainting, confusion, or shortness of breath. Sudden falls in blood pressure may point to potentially serious underlying causes, which can include:
Treatment of hypotension depends on its cause:
For more severe cases, physicians might also administer fludrocortisone or midodrine to increase blood pressure. Shock from hypotension should be treated promptly to ensure proper function of organs.
Chronic fatigue syndrome has also been associated with low blood pressure. Prolonged tiredness, despite adequate rest, may require reassessment of blood pressure levels. Fatigue secondary to hypotension will impact functionality and thus requires assessment and treatment of the cause.
If your blood pressure readings are low consistently and without symptoms, you probably have nothing to worry about. If you do have symptoms like dizziness, fainting, or confusion, you need to go to the doctor. Blood pressure checks are usually conducted regularly. Once you are aware of your own normal baseline, you will know right away when there is something wrong.
Credit: AI generated image
Although classified as a rare disease, hemophilia in India is widespread and overlooked. According to the World Federation of Hemophilia (WFH), about 75 percent of individuals affected by hemophilia are undiagnosed across the globe, hence lack proper healthcare, which is associated with an elevated incidence of complications.
In India, the gap is stark. The WFH has provided statistics that indicate that India has one of the largest hemophilia populations worldwide, with approximately 24,000 patients registered, whereas the estimated prevalence is approximately 1.2 lakhs, indicating that a large pool remains undiagnosed or outside the care pathway.
The implications of being undiagnosed or not receiving appropriate medical care are both clinical and non-clinical. Many people are losing milestones, dreams, or are otherwise negatively affected by the anxiety associated with living with an undiagnosed condition. For clinicians, this "hidden population" poses a daunting and deeply concerning challenge.
They are not missing; rather, they remain unseen due to delayed recognition, often presenting only after irreversible damage has already set in.
Children with persistent symptoms of joint swelling, unexplained excessive bleeding after sustaining minor injuries, and other symptoms are usually diagnosed with other health conditions, like bone injuries or nutrient deficiencies.
This period of clinical ambiguity can extend for months or even years before appropriate diagnostic testing and referrals are initiated.
Joint damage is often established by the time a conclusive diagnosis is made, and may lead to reduced mobility or early deformity, chronic pain, disability, and loss of functional independence. Severe complications, including intracranial hemorrhage, continue to pose significant risks in inadequately treated patients.
The barriers to timely diagnosis are both clinical and systemic, ranging from limited awareness and low suspicion among primary care providers to fragmented referral pathways and frequent misdiagnosis. At the systemic level, uneven access to the diagnostic infrastructure persists.
The availability of coagulation tests and specialists is mainly limited to the tertiary settings, thus posing a problem for patients from tier 2 and tier 3 regions. It is vital to understand the costs associated with a delay in diagnosis in the context of how far hemophilia care has evolved.
Over the past decade, advances in treatment have significantly improved patient outcomes. Clinical goals are no longer limited to managing bleeds as they occur, but to preventing them altogether, making “zero bleeds” an achievable reality. This is where prophylaxis takes centre stage.
Where on-demand therapy treats hemophilia symptoms only after a bleeding episode has occurred, prophylaxis seeks to prevent bleeding completely and is considered the gold standard of care globally. It can bring about reductions in bleeds by up to 90% and maintain healthy joints, allowing children to achieve near-normal musculoskeletal development.
When initiated early, prophylaxis can prevent the onset of joint damage. However, when patients are diagnosed late, they often enter care only after irreversible complications have already occurred. This makes early identification not just important, but decisive in altering disease trajectory.
Encouragingly, progress is visible. Several Indian states have demonstrated that publicly funded hemophilia programs, including access to prophylaxis and decentralized care models, can significantly improve patient outcomes. Initiatives that integrate early patient identification, diagnostic access, and coordinated care pathways are beginning to reduce delays and expand equitable access.
These state-led efforts offer important lessons for making prophylaxis the national standard of care in India. Recognizing hemophilia early and initiating prophylaxis in time is not just a clinical goal; it is the most critical step in changing the life course of these patients.
Credit: iStock
Irritable Bowel Syndrome (IBS) is a common but often overlooked gastrointestinal disorder; as a result, IBS is very prevalent, with less than 15% being diagnosed.
Individuals frequently experience recurrent symptoms such as bloated abdomen, abdominal pain, gas, diarrhea, or constipation, and normalize these symptoms over time or attribute them to "something they ate" or everyday stresses. Therefore, IBS remains undiagnosed for many years.
Why Diagnosis Is Often Delayed
One reason for this delay in being diagnosed is that the symptoms occur intermittently. It is also important to note that the presentation of these symptoms is inconsistent and unpredictable; there may be episodes where the IBS can last many days, and then completely resolve, thus providing a false sense of relief. Therefore, many individuals choose to delay consulting with a physician due to their belief that the symptoms they are experiencing are not serious.
Stigma Around Digestive Health
Another contributing factor is that there is still a degree of reluctance or discomfort associated with discussing problems related to the gastrointestinal tract openly; this only further complicates under-reporting statistics.
A ‘Functional’ Disorder Adds to Confusion
Finally, IBS is a functional disorder. Therefore, routine diagnostic testing will not reveal any visible abnormalities. Many patients may assume that the symptoms they are experiencing are not "real" or are not significant enough to warrant seeking medical attention, even though the discomfort they experience can be quite significant and affect their daily lives.
If you continually ignore symptoms of IBS, it will hurt your quality of life, productivity, and mental health. If you have persistent discomfort, you are likely to develop anxious feelings about eating, socializing, and travelling. Furthermore, if you don't manage your symptoms, you may experience a combination of untreated IBS with one or more other illnesses that are either gastrointestinal or metabolic; consequently, establishing the correct diagnosis for your IBS will be increasingly difficult as time goes on.
It is of the utmost importance to identify and respond to early warning signs of IBS as quickly as possible. A thorough evaluation can rule out other illnesses and provide a pathway for appropriate management, including dietary modifications, stress management techniques, and, if necessary, medical treatment.
Once you address your IBS, you will experience better control of your symptoms and eliminate the long-term consequences of IBS, both physically and psychologically.
Credit: AI generated image
India has long been considered a low-incidence country for colorectal cancer, but that picture is changing fast. Based on current trends, India could see a sharp rise in colorectal cancer cases and deaths by 2035, driven largely by rapid urbanization and the widespread adoption of westernized lifestyles. The burden is expected to hit urban populations hardest, making timely awareness and screening no longer optional, but essential.
Perhaps the most alarming shift is who is getting diagnosed. Over the past decade, there has been a worrying increase in colorectal cancer among younger Indians, patients in their 40s and 50s who would not traditionally have been considered high risk. Clinical observations suggest that as many as one in five colorectal cancer patients today falls into this younger age group.
What makes this particularly concerning is not just the frequency, but the severity. These younger patients are presenting with more node-positive disease and poorer tumor histology than their older counterparts. The cancer is often more aggressive and more advanced at the time of diagnosis, a direct consequence of delayed recognition and a lack of awareness among younger demographics.
The red flags for colorectal cancer are not subtle. Rectal bleeding, persistent abdominal discomfort, pain, and a noticeable change in bowel habits are the most common warning signs. In some cases, patients may present with bowel obstruction. And yet, these symptoms are routinely dismissed, mistaken for hemorrhoids, acidity, or irritable bowel syndrome, until the disease has progressed significantly.
The message from clinicians is unambiguous – never ignore these symptoms, regardless of age.
While colorectal cancer can affect anyone, certain individuals carry a substantially higher risk and should be especially vigilant. These include those with a family history of colorectal or uterine cancer, patients with inflammatory bowel disease, individuals with multiple gastrointestinal polyps, and those with features suggestive of hereditary cancer syndromes.
For anyone with a relevant family history, specialists strongly advise seeking a formal genetic risk assessment. Early identification of hereditary risk can be lifesaving, and the conversation with a doctor should not be delayed.
The most effective way to defeat cancer is to detect it early, ideally before it becomes cancer at all.
While routine population-level colorectal cancer screening is not yet standard practice in India, advanced diagnostic tools are increasingly available at quaternary care centers. These include colonoscopy, fecal occult blood testing, CT colonography, flexible sigmoidoscopy, double-contrast barium enema, and DNA stool testing. Importantly, these methods can identify precancerous polyps before malignant transformation, providing an opportunity to intervene well before a cancer develops.
In Western countries, organized screening programs have already demonstrated meaningful reductions in colorectal cancer mortality. The tools are now available in India; what is needed is the awareness and urgency to use them.
For those who do receive a colorectal cancer diagnosis, the landscape of treatment has transformed dramatically over the past two decades. Leading oncology centers in India now follow a personalized, multidisciplinary approach combining surgery, combination chemotherapy, radiation where indicated, and biomarker-guided targeted therapies tailored to each patient's tumor profile.
In metastatic disease, targeted therapies designed around tumor characteristics and biomarkers have revolutionized outcomes. Minimally invasive techniques, including laparoscopic surgery and advanced robotic surgical systems such as the Da Vinci Xi, have made recovery faster, less painful, and significantly shorter, improving quality of life alongside survival rates.
Advanced or metastatic colorectal cancer does not mean the end of hope. With modern chemotherapy and immunotherapy protocols, many patients with liver or lung metastases are being successfully downstaged, allowing surgical intervention that was previously not possible.
Specialized centres in India are now performing high volumes of parenchyma-sparing, image-guided liver resections for colorectal liver metastasis, with outcomes comparable to the best institutions globally.
The Way Forward
The priorities are clear: build awareness around symptoms, promote regular screening among high-risk individuals, and ensure that those diagnosed, at any stage, have access to specialized, multidisciplinary care.
Colorectal cancer, even when diagnosed late, is increasingly a beatable disease. The combination of early detection, advanced treatment, and the right medical expertise means that for a growing number of patients, a return to normal life is not just possible, it is the expectation.
© 2024 Bennett, Coleman & Company Limited